It is pleasing to see the Federal Government take action to improve access to unregistered medical cannabis products, by removing red tape on the importation of overseas-manufactured products.
The Government is continuing to work closely with senior clinicians on the Tasmanian Controlled Access Scheme, which will be delivered this year - as we always said it would.
The CAS will allow patients to be prescribed with unregistered medical cannabis products by an appropriately qualified, specialist medical practitioner, under certain conditions, including peer review.
It will achieve a balance by providing a process to prescribe medical cannabis products that are not registered under the Therapeutic Goods Administration as safely as possible with medical support.